Patient Perspective: Key Aspects of Supportive Care in the EGFR-Mutant Advanced NSCLC Journey
Panelists discuss key aspects of supportive care from the patient perspective in the EGFR-mutant advanced NSCLC journey, focusing on the strategies and resources that have been most helpful in managing symptoms and improving quality of life throughout treatment.
Video Player is loading.
EP: 1.Overview of EGFR-Mutant Advanced NSCLC
EP: 2.EGFR-Mutant NSCLC Diagnosis: Insights from Patients and Clinicians
EP: 3.Coordinating Care for Patients with Advanced EGFR-Mutant NSCLC: A Multidisciplinary Approach
EP: 4.Multidisciplinary Care of EGFR-Mutant Advanced NSCLC: A Patient Perspective
EP: 5.Tailoring Patient Education and Resources in EGFR-Mutant Advanced NSCLC
EP: 6.Navigating EGFR-Mutant Advanced NSCLC Cancer Treatment: A Patient's Journey
EP: 7.Shared Decision Making in EGFR-Mutant Advanced NSCLC
EP: 8.Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC
EP: 9.Intricacies of EGFR-Mutated NSCLC Care From the Patient Perspective
EP: 10.Patient Perspectives on Managing Side Effects from Amivantamab
EP: 11.Comprehensive Supportive Care for EGFR-Mutant Advanced NSCLC
Now Viewing
EP: 12.Patient Perspective: Key Aspects of Supportive Care in the EGFR-Mutant Advanced NSCLC Journey
EP: 13.Future Perspectives in EGFR-Mutant Advanced NSCLC
Video content above is prompted by the following:
- Dr. Spira asks Melinda: Can you briefly share key aspects of your supportive care that helped you through your journey?
Recent Videos
Imaging Quality in Prostate Cancer: Impact on Treatment Decision-Making
Exploring Next-Line Options: Therapies Beyond Trastuzumab Deruxtecan in HER2+ MSS Gastric Cancer
Selecting the Optimal PSMA PET Imaging Agent: Clinical Considerations and Data-Driven Decisions
MSS Status and Pembrolizumab: Assessing Benefits and Considering Combinations Beyond Progression in Upper GI Cancer
Second-Line Treatment for Gastric Adenocarcinoma
Advanced Metastatic Gastric Adenocarcinoma: Treatment Approaches
Gastric Adenocarcinoma: Current Treatment Landscape
Adjuvant Nivolumab in Gastric Cancers & CheckMate 8HW
Esophageal/Gastric Adenocarcinoma Standard of Care
BESPOKE: Study Design, Efficacy End Points and Methods
